Global RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Regional Outlook and Forecast, 2022 - 2028

The Global RNA Analysis Market size is expected to reach $28 billion by 2028, rising at a market growth of 15.6% CAGR during the forecast period.

Research on RNA analysis spans a broad spectrum of issues, from an in-depth examination of the transcriptome of the entire collection of RNA transcripts encoded by a genome to examining the effects of individual short noncoding RNAs on particular genes. The method used to produce RNA in a lab setting from a DNA template is known as in vitro transcription.

For use in procedures like in vitro translation, the investigation of RNA viruses, and RNA: protein interaction investigations, RNA is produced from DNA templates using in vitro transcription devices. For use in RNA analysis research, single-stranded RNA probes, microgram amounts of specified RNA transcripts, and antisense RNA are all prepared using riboprobe systems.

RNA sequencing (RNA-Seq) makes use of high-throughput sequencing techniques to shed light on a cell's transcriptome. RNA-Seq offers far larger coverage and better resolution of the dynamic of the transcriptome than earlier Sanger sequencing- and microarray-based approaches. The data produced by RNA-Seq enable the discovery of novel transcripts, recognition of alternatively spliced genes, and detection of allele-specific expression in addition to quantifying gene expression.

Researchers have been able to better understand the functional intricacy of the transcription due to recent improvements in the RNA-Seq methodology, which includes sample preparation, library creation, and data analysis. RNA-Seq can be used to explore several RNA populations, including total RNA, pre-mRNA, and noncoding RNA, such as microRNA and long ncRNA, in addition to polyadenylated messenger RNA (mRNA) transcripts.

An overview of RNA-Seq methodologies, including applications, experimental planning, and technological difficulties. The fundamental tenet of molecular biology describes the progression of information from DNA encoded in genes to RNA that is translated into proteins. The phenotype of an organism is the final manifestation of this genetic information altered by environmental circumstances.

COVID-19 Impact Analysis

Due to Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR), there is a rising demand for testing and diagnosis during the COVID 19 pandemic, which is anticipated to propel market expansion. Since COVID-19 is an infectious disease, its prevalence will likely increase during the predicted period. To analyze and examine the infection, RNAs are isolated from the BAL-Bronchoalveolar Lavage Fluid of the COVID patient. This is being used to offer therapeutic guidance on anti-inflammatory drugs and to comprehend the host and response's molecular architectures better to create effective therapies. As a result, the demand for diagnostics and research is rising, which is likely to fuel market expansion.

Market Growth Factors

Demand For Personalized Medication Is Rising

The identification, classification, and treatment of many diseases are being changed by personalized medicine, which has emerged as a major topic of research in the healthcare sector. These developments are especially noticeable in RNA analysis. The number of tailored medications, therapies, and diagnostic tools has grown since 2006, and this trend is anticipated to continue in the years to come, according to a 2017 report by the Personalized Medicine Coalition. Personalized medicine is the practice of tailoring a patient's medical care to their particular needs.

Greater Emphasis On Biomarker Discovery

For determining the toxicity and efficacy of medications, biomarker identification and its clinical applications have streamlined the drug discovery and development process. Additionally, biomarkers are essential in providing a better understanding of the disease route and progression for conditions like cancer, CVD, and neurological disorders. Pharmaceutical and biotechnology businesses run extremely sophisticated and expensive drug development operations.

Market Restraining Factors

High Capital Expenditures Along With Lack Qualified Professionals

With the widespread use of novel applications, RNA Analysis research is now used for everything from the identification of new drugs, vaccines, and diagnostic targets to toxicology, the identification of surrogate markers of activity in clinical research, and the capacity to provide details on the mechanisms of drug action. It is also used to identify surrogate markers of activity in other fields. This adds to the high cost of analytics by requiring the use of many platforms, devices, and laboratory documentation systems.

Technology Outlook

On the basis of Technology, the RNA Analysis market is divided into Real Time-PCR (qPCR) Technology, Microarray Technology, Sequencing Technology, and Others. The Sequencing Technology segment witnessed a significant revenue share in the RNA Analysis Market in 2021. It is due to the development of precision medicine as well as the rise in RNA sequencing research investigations due to its advantages over traditional methods. In essence, the market expansion is being driven by the growing use of RNA sequencing in cancer and agricultural research.

Product Outlook

Based on the Product, the RNA Analysis market is segmented into Instruments, Kits & Reagents, and Services. The Services segment recorded a substantial revenue share in the RNA Analysis Market in 2021. As a full Sample to Insight service, RNA Sequencing Services offers RNA separation, library preparation, sequencing, and data analysis. From the first consultation through sophisticated data analysis and interpretation, everything is covered by this service.

Application Outlook

By Application, the RNA Analysis market is bifurcated into Construction of RNA Expression Atlas, Epigenetics, Infectious Diseases & Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development &Delivery of RNA Therapeutics, and Others. The Epigenetics segment registered a significant revenue share in the RNA Analysis Market in 2021. It is due to the changes in gene expression that are permanent and heritable but do not affect the DNA sequence referred to. However, epigenetic alterations can also occur in RNA, commonly known as the epitranscriptome, although further research is needed to determine whether these modifications are heritable.

End-Use Outlook

By End-use, the RNA Analysis market is classified into Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), and Hospitals & Clinics. The Contract Research Organizations (CROs) segment recorded a substantial revenue share in the RNA Analysis Market in 2021. It is due to the Key market participants' strategic initiatives aid in the segment's expansion. For instance, 10x Genomics announced in January 2022 that three of the industry's top CROs had joined its 10x Certified Service Provider Network.

RNA Analysis Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 10.3 Billion
Market size forecast in 2028	USD 28 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 15.6% from 2022 to 2028
Number of Pages	327
Number of Tables	504
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product, Technology, End-use, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Demand For Personalized Medication Is Rising Greater Emphasis On Biomarker Discovery
Restraints	High Capital Expenditures Along With Lack Qualified Professionals

Regional Outlook

Region-wise, the RNA Analysis market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the highest revenue share in the RNA Analysis Market in 2021. It is the rapid advancement of structure-based medication designs, the growing importance of RNA Analysis research, and substantial investments in biopharmaceutical research and innovation that are all credited with the growth.

Free Valuable Insights: Global RNA Analysis Market size to reach USD 28 Billion by 2028

KBV Cardinal Matrix - RNA Analysis Market Competition Analysis

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche AG and Thermo Fisher Scientific, Inc. are the forerunners in the RNA Analysis Market. Companies such as Danaher Corp., Bio-Rad Laboratories, Inc., Merck Group are some of the key innovators in RNA Analysis Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.

Strategies deployed in RNA Analysis Market

» Partnerships, Collaborations and Agreements:

• May-2022: Illumina came into a partnership with Deerfield Management, a healthcare investment management company. Together, the companies aimed to utilize genomic tools and inborn knowledge to pick programs with a higher chance of success to lower research and growth expenses and drive the permission of cutting-edge treatments.
• Feb-2022: QIAGEN formed a partnership with Singular Genomics Systems, a company leveraging novel next-generation sequencing. With this partnership, QIAGEN aimed to verify its QIAseq kits, a product line for both RNA and DNA sample prep, with the G4 analysis platform. Additionally, this partnership would highlight QIAGEN's dedication to delivering a plug-and-play solution for consumers to combine the G4 into living NGS workflows.
• Feb-2022: Thermo Fisher Scientific joined hands with Moderna, a biotechnology company developing messenger RNA. Under this collaboration, the companies aimed to allow reliable large-scale manufacturing in the U.S. of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA drugs in its channel.
• Feb-2022: Merck KGaA came into a partnership with eTheRNA, a science and technology organization. Together the companies would target messenger RNA therapeutics using eTheRNA’s mRNA and lipid nanoparticle technologies in multiple model methods. Additionally, mRNA encoding antigens would be selected by Merck KGaA as suitable for human diseases. Moreover, eTheRNA acquires immunotherapies that target the essential role of dendritic cells in the human immune system.
• Jan-2022: Illumina came into a partnership with SomaLogic, which monitors health and disease through the analysis of protein concentration changes in biological samples. Through this partnership, SomaLogic to obtain the SomaScan Proteomics Assay within Illumina's existing and future high throughput next-generation sequencing venues. Additionally, Partnership would drive Next-Generation Sequencing into the largest Area of the Proteomics Market with Ultra-high Plexity Workflow, and Ultra-high Throughput.
• Aug-2021: Agilent signed an agreement with Partek Incorporated, a provider of analytics software and services for life sciences. Through this agreement, the companies aimed to combine Partek Flow bioinformatics software within the Agilent Alissa Clinical Informatics Platform. Additionally, the integration would provide an entire end-to-end analysis workflow that is flexible, robust, and personalized to fulfill Agilent consumer needs. Moreover, the agreement permits Agilent to resell Partek Flow software via the Alissa Portal for a single-point solution.
• Aug-2021: Roche came into a partnership with Shape Therapeutics, which serves as a biotechnology company. Together, the companies aimed to create gene treatments for precise targets in Parkinson’s disease, Alzheimer’s disease, and rare disease areas. Additionally, the partnership would utilize Shape’s RNA editing medium, RNA fix, and the AAVid technology platform for tissue-specific adeno-associated viruses to develop gene therapy for neuroscience and rare condition symptoms.
• Aug-2021: QIAGEN came into a partnership with GT Molecular, a leader in providing personalized, highly sensitive digital PCR and qPCR tests. Through this partnership, the companies aimed to deliver a comprehensive wastewater workflow solution developed to allow management of COVID-19 outbreaks by U.S. and Canadian laboratories, with forthcoming opportunities to deliver the solution in other countries.
• Jan-2021: Genentech, a member of the Roche Group, joined hands with Ribometrix, a platform therapeutics company. With this acquisition, the company aimed to create and discover novel RNA-targeted little molecule therapeutics against various targets. Moreover, Ribometrix has built abilities to drug-specific RNAs, and look forward to a fertile collaboration to examine this growing area of science.
• Apr-2020: Roche teamed up with Arrakis Therapeutics, a biopharmaceutical company pioneering the finding of a new type of small molecule medicine. Together, the companies focused on the discovery of RNA-targeted small molecule drugs against a general set of targets across all of Roche’s development and research areas. Additionally, Arrakis would manage discovery and research actions for each target to a defined point, at which time Roche would have the right to seek further clinical and preclinical development.

» Product Launches and Product Expansions:

• Jun-2022: Bio-Rad Laboratories introduced SEQuoia Express Stranded RNA Library Prep Kit. The kit delivers biopharmaceutical and analysis scientists with an easy-to-use solution for creating powerful libraries to sustain efficient RNA-Seq workflows for complete transcriptome profiling. Additionally, the kit is a cost-effective and automation-friendly solution to the present problems in the library era.
• Mar-2022: Illumina introduced TruSight Oncology Comprehensive, a single test that assesses multiple tumor genes. The new kit protects a wide field of mutations and current and developing biomarkers linked with the European Society for Medical Oncology guidelines, clinical trials, and drug labels, maximizing the probabilities of discovering actionable data from each patient's biopsy.
• Dec-2021: Eurofins Technologies launched GSD NovaType Detect + Select K417N SARS-CoV-2 test. The new kit is declared to be a quick and cost-effective solution for witnessing the Omicron variant before specimens are approved by whole-genome sequencing.
• Oct-2021: Thermo Fisher Scientific unveiled Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully incorporated digital PCR system. The new dPCR is a biotechnological improvement of traditional polymerase chain reaction methods that can be utilized to instantly quantify and clonally amplify nucleic acid strands such as DNA, cDNA, or RNA. Additionally, the system is developed to deliver highly precise and uniform results in genetic analysis and analysis within 90 minutes.
• Jun-2021: QIAGEN unveiled QIAprep&amp CRISPR Kit along with CRISPR Q-Primer Solutions. The new solution permits investigators to examine edited genetic material with unparalleled pace and effectiveness to resolve how their interventions have transformed the function of the DNA sequence in question. Moreover, the solution delivers scientists with a sensitive, all-in-one process for describing so-called knock-outs developed from guide RNA and knock-ins from small insertions while gene editing.
• May-2021: Bio-Rad Laboratories unveiled SEQuoia RiboDepletion Kit, which improves assay efficiency by stopping unessential ribosomal RNA fragments from an RNA-Seq library. The new SEQuoia RiboDepletion Kit is developed for genomics investigators targeting infrequent transcripts or operating with a restricted or degraded sample. Moreover, the efficient detection of irrelevant rRNA fragments helps decrease the prices of sequencing RNA samples.
• Mar-2021: Promega Corporation introduced XpressAmp Direct Amplification Reagents, stimulating RNA extraction-free specimen practice. With this launch, laboratories experimenting with COVID-19 have a unique tool that permits them to ignore the potentially bottlenecked RNA extraction step of the workflow and move straight to polymerase chain reaction amplification.
• Feb-2021: Eurofins introduced Ultra-Fast Extraction-Free RT-PCR Method. The new kit is designed for the qualitative identification of SARS-CoV-2 from human nasopharyngeal swabs, eluted straight into deionized water without an extra RNA extraction process.
• Sep-2020: Agilent Technologies introduced SureSelect XT HS2 RNA Reagent Kit. The new solution offers a modular format that allows an easy and parallel approach for both DNA and RNA samples, permitting clients to simplify and reduce their workflow without losing time optimizing different kits for different sample types.
• Mar-2020: Thermo Fisher Scientific launched Thermo Scientific AcroMetrix Coronavirus 2019 RNA Control. The new Thermo Fisher developed and designed this authority as a synthetic RNA, non-infectious control to support labs validating and monitoring COVID-19 molecular diagnostic tests.

» Acquisitions and Mergers:

• Feb-2022: Merck completed the acquisition of Exelead, a biopharmaceutical contract development, and manufacturing business. Through this acquisition, Exelead’s leading abilities, and highly experienced crew, Merck acquires a crucial landmark in evolving one of the supreme CDMO players in mRNA vaccines and therapeutics, delivering a combined CDMO across the mRNA value chain from pre-clinical to retail.
• Jun-2021: Danaher completed the acquisition of Aldevron, a US-based biotech business. With this acquisition, Danaher would expand its abilities into the crucial field of genomic medicine and help consumers and their essential task to obtain more life-saving treatments and vaccines to market quickly.
• May-2021: Roche took over GenMark Diagnostics, a supreme provider of multiplex molecular diagnostic solutions. With this acquisition, Roche focused on developing its offering of molecular diagnostics with GenMark’s expertise in syndromic testing. Additionally, The companies consider that GenMark’s ePlex systems would improve Roche’s position in controlling antibiotic resistance and infectious diseases.
• Feb-2021: Thermo Fisher Scientific took over Mesa Biotech, a privately held point-of-care molecular diagnostic enterprise. With this acquisition, the company aimed to integrate Thermo Fisher's operational excellence, permit to raw materials, and current distribution and sales pipelines within Mesa’s creative platform, Thermo can instantly scale manufacturing volume, propel cost-effectiveness and convey much-needed diagnostics to the industry quickly and at greater scale.

» Geographical Expansions:

• Apr-2021: Promega Corporation expanded its geographical footprint by establishing Kornberg Center on its Fitchburg, WI campus. The expansion would sustain core product and technology growth in life science research, cellular and genetic identity, molecular biology, clinical diagnostic, and scientific training and applications.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Kits & Reagents
• Instruments
• Services

By Technology

• Real Time-PCR (qPCR) Technology
• Sequencing Technology
• Microarray Technology
• Others

By End-use

• Government Institutes & Academic Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)

By Application

• Infectious Diseases & Pathogenesis
• Epigenetics
• RNA Structure & Molecular Dynamics
• Development & Delivery of RNA Therapeutics
• Construction of RNA Expression Atlas
• Alternative RNA Splicing
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific Group
• Merck Group
• Promega Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global RNA Analysis Market, by Product
1.4.2 Global RNA Analysis Market, by Technology
1.4.3 Global RNA Analysis Market, by End-use
1.4.4 Global RNA Analysis Market, by Application
1.4.5 Global RNA Analysis Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players

Chapter 4. Global RNA Analysis Market by Product
4.1 Global Kits & Reagents Market by Region
4.2 Global Instruments Market by Region
4.3 Global Services Market by Region

Chapter 5. Global RNA Analysis Market by Technology
5.1 Global Real Time-PCR (qPCR) Technology Market by Region
5.2 Global Sequencing Technology Market by Region
5.3 Global Microarray Technology Market by Region
5.4 Global Others Market by Region

Chapter 6. Global RNA Analysis Market by End-use
6.1 Global Government Institutes & Academic Centers Market by Region
6.2 Global Hospitals & Clinics Market by Region
6.3 Global Pharmaceutical & Biotechnology Companies Market by Region
6.4 Global Contract Research Organizations (CROs) Market by Region

Chapter 7. Global RNA Analysis Market by Application
7.1 Global Infectious Diseases & Pathogenesis Market by Region
7.2 Global Epigenetics Market by Region
7.3 Global RNA Structure & Molecular Dynamics Market by Region
7.4 Global Development & Delivery of RNA Therapeutics Market by Region
7.5 Global Construction of RNA Expression Atlas Market by Region
7.6 Global Alternative RNA Splicing Market by Region
7.7 Global Others Market by Region

Chapter 8. Global RNA Analysis Market by Region
8.1 North America RNA Analysis Market
8.1.1 North America RNA Analysis Market by Product
8.1.1.1 North America Kits & Reagents Market by Country
8.1.1.2 North America Instruments Market by Country
8.1.1.3 North America Services Market by Country
8.1.2 North America RNA Analysis Market by Technology
8.1.2.1 North America Real Time-PCR (qPCR) Technology Market by Country
8.1.2.2 North America Sequencing Technology Market by Country
8.1.2.3 North America Microarray Technology Market by Country
8.1.2.4 North America Others Market by Country
8.1.3 North America RNA Analysis Market by End-use
8.1.3.1 North America Government Institutes & Academic Centers Market by Country
8.1.3.2 North America Hospitals & Clinics Market by Country
8.1.3.3 North America Pharmaceutical & Biotechnology Companies Market by Country
8.1.3.4 North America Contract Research Organizations (CROs) Market by Country
8.1.4 North America RNA Analysis Market by Application
8.1.4.1 North America Infectious Diseases & Pathogenesis Market by Country
8.1.4.2 North America Epigenetics Market by Country
8.1.4.3 North America RNA Structure & Molecular Dynamics Market by Country
8.1.4.4 North America Development & Delivery of RNA Therapeutics Market by Country
8.1.4.5 North America Construction of RNA Expression Atlas Market by Country
8.1.4.6 North America Alternative RNA Splicing Market by Country
8.1.4.7 North America Others Market by Country
8.1.5 North America RNA Analysis Market by Country
8.1.5.1 US RNA Analysis Market
8.1.5.1.1 US RNA Analysis Market by Product
8.1.5.1.2 US RNA Analysis Market by Technology
8.1.5.1.3 US RNA Analysis Market by End-use
8.1.5.1.4 US RNA Analysis Market by Application
8.1.5.2 Canada RNA Analysis Market
8.1.5.2.1 Canada RNA Analysis Market by Product
8.1.5.2.2 Canada RNA Analysis Market by Technology
8.1.5.2.3 Canada RNA Analysis Market by End-use
8.1.5.2.4 Canada RNA Analysis Market by Application
8.1.5.3 Mexico RNA Analysis Market
8.1.5.3.1 Mexico RNA Analysis Market by Product
8.1.5.3.2 Mexico RNA Analysis Market by Technology
8.1.5.3.3 Mexico RNA Analysis Market by End-use
8.1.5.3.4 Mexico RNA Analysis Market by Application
8.1.5.4 Rest of North America RNA Analysis Market
8.1.5.4.1 Rest of North America RNA Analysis Market by Product
8.1.5.4.2 Rest of North America RNA Analysis Market by Technology
8.1.5.4.3 Rest of North America RNA Analysis Market by End-use
8.1.5.4.4 Rest of North America RNA Analysis Market by Application
8.2 Europe RNA Analysis Market
8.2.1 Europe RNA Analysis Market by Product
8.2.1.1 Europe Kits & Reagents Market by Country
8.2.1.2 Europe Instruments Market by Country
8.2.1.3 Europe Services Market by Country
8.2.2 Europe RNA Analysis Market by Technology
8.2.2.1 Europe Real Time-PCR (qPCR) Technology Market by Country
8.2.2.2 Europe Sequencing Technology Market by Country
8.2.2.3 Europe Microarray Technology Market by Country
8.2.2.4 Europe Others Market by Country
8.2.3 Europe RNA Analysis Market by End-use
8.2.3.1 Europe Government Institutes & Academic Centers Market by Country
8.2.3.2 Europe Hospitals & Clinics Market by Country
8.2.3.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
8.2.3.4 Europe Contract Research Organizations (CROs) Market by Country
8.2.4 Europe RNA Analysis Market by Application
8.2.4.1 Europe Infectious Diseases & Pathogenesis Market by Country
8.2.4.2 Europe Epigenetics Market by Country
8.2.4.3 Europe RNA Structure & Molecular Dynamics Market by Country
8.2.4.4 Europe Development & Delivery of RNA Therapeutics Market by Country
8.2.4.5 Europe Construction of RNA Expression Atlas Market by Country
8.2.4.6 Europe Alternative RNA Splicing Market by Country
8.2.4.7 Europe Others Market by Country
8.2.5 Europe RNA Analysis Market by Country
8.2.5.1 Germany RNA Analysis Market
8.2.5.1.1 Germany RNA Analysis Market by Product
8.2.5.1.2 Germany RNA Analysis Market by Technology
8.2.5.1.3 Germany RNA Analysis Market by End-use
8.2.5.1.4 Germany RNA Analysis Market by Application
8.2.5.2 UK RNA Analysis Market
8.2.5.2.1 UK RNA Analysis Market by Product
8.2.5.2.2 UK RNA Analysis Market by Technology
8.2.5.2.3 UK RNA Analysis Market by End-use
8.2.5.2.4 UK RNA Analysis Market by Application
8.2.5.3 France RNA Analysis Market
8.2.5.3.1 France RNA Analysis Market by Product
8.2.5.3.2 France RNA Analysis Market by Technology
8.2.5.3.3 France RNA Analysis Market by End-use
8.2.5.3.4 France RNA Analysis Market by Application
8.2.5.4 Russia RNA Analysis Market
8.2.5.4.1 Russia RNA Analysis Market by Product
8.2.5.4.2 Russia RNA Analysis Market by Technology
8.2.5.4.3 Russia RNA Analysis Market by End-use
8.2.5.4.4 Russia RNA Analysis Market by Application
8.2.5.5 Spain RNA Analysis Market
8.2.5.5.1 Spain RNA Analysis Market by Product
8.2.5.5.2 Spain RNA Analysis Market by Technology
8.2.5.5.3 Spain RNA Analysis Market by End-use
8.2.5.5.4 Spain RNA Analysis Market by Application
8.2.5.6 Italy RNA Analysis Market
8.2.5.6.1 Italy RNA Analysis Market by Product
8.2.5.6.2 Italy RNA Analysis Market by Technology
8.2.5.6.3 Italy RNA Analysis Market by End-use
8.2.5.6.4 Italy RNA Analysis Market by Application
8.2.5.7 Rest of Europe RNA Analysis Market
8.2.5.7.1 Rest of Europe RNA Analysis Market by Product
8.2.5.7.2 Rest of Europe RNA Analysis Market by Technology
8.2.5.7.3 Rest of Europe RNA Analysis Market by End-use
8.2.5.7.4 Rest of Europe RNA Analysis Market by Application
8.3 Asia Pacific RNA Analysis Market
8.3.1 Asia Pacific RNA Analysis Market by Product
8.3.1.1 Asia Pacific Kits & Reagents Market by Country
8.3.1.2 Asia Pacific Instruments Market by Country
8.3.1.3 Asia Pacific Services Market by Country
8.3.2 Asia Pacific RNA Analysis Market by Technology
8.3.2.1 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country
8.3.2.2 Asia Pacific Sequencing Technology Market by Country
8.3.2.3 Asia Pacific Microarray Technology Market by Country
8.3.2.4 Asia Pacific Others Market by Country
8.3.3 Asia Pacific RNA Analysis Market by End-use
8.3.3.1 Asia Pacific Government Institutes & Academic Centers Market by Country
8.3.3.2 Asia Pacific Hospitals & Clinics Market by Country
8.3.3.3 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
8.3.3.4 Asia Pacific Contract Research Organizations (CROs) Market by Country
8.3.4 Asia Pacific RNA Analysis Market by Application
8.3.4.1 Asia Pacific Infectious Diseases & Pathogenesis Market by Country
8.3.4.2 Asia Pacific Epigenetics Market by Country
8.3.4.3 Asia Pacific RNA Structure & Molecular Dynamics Market by Country
8.3.4.4 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country
8.3.4.5 Asia Pacific Construction of RNA Expression Atlas Market by Country
8.3.4.6 Asia Pacific Alternative RNA Splicing Market by Country
8.3.4.7 Asia Pacific Others Market by Country
8.3.5 Asia Pacific RNA Analysis Market by Country
8.3.5.1 China RNA Analysis Market
8.3.5.1.1 China RNA Analysis Market by Product
8.3.5.1.2 China RNA Analysis Market by Technology
8.3.5.1.3 China RNA Analysis Market by End-use
8.3.5.1.4 China RNA Analysis Market by Application
8.3.5.2 Japan RNA Analysis Market
8.3.5.2.1 Japan RNA Analysis Market by Product
8.3.5.2.2 Japan RNA Analysis Market by Technology
8.3.5.2.3 Japan RNA Analysis Market by End-use
8.3.5.2.4 Japan RNA Analysis Market by Application
8.3.5.3 India RNA Analysis Market
8.3.5.3.1 India RNA Analysis Market by Product
8.3.5.3.2 India RNA Analysis Market by Technology
8.3.5.3.3 India RNA Analysis Market by End-use
8.3.5.3.4 India RNA Analysis Market by Application
8.3.5.4 South Korea RNA Analysis Market
8.3.5.4.1 South Korea RNA Analysis Market by Product
8.3.5.4.2 South Korea RNA Analysis Market by Technology
8.3.5.4.3 South Korea RNA Analysis Market by End-use
8.3.5.4.4 South Korea RNA Analysis Market by Application
8.3.5.5 Singapore RNA Analysis Market
8.3.5.5.1 Singapore RNA Analysis Market by Product
8.3.5.5.2 Singapore RNA Analysis Market by Technology
8.3.5.5.3 Singapore RNA Analysis Market by End-use
8.3.5.5.4 Singapore RNA Analysis Market by Application
8.3.5.6 Malaysia RNA Analysis Market
8.3.5.6.1 Malaysia RNA Analysis Market by Product
8.3.5.6.2 Malaysia RNA Analysis Market by Technology
8.3.5.6.3 Malaysia RNA Analysis Market by End-use
8.3.5.6.4 Malaysia RNA Analysis Market by Application
8.3.5.7 Rest of Asia Pacific RNA Analysis Market
8.3.5.7.1 Rest of Asia Pacific RNA Analysis Market by Product
8.3.5.7.2 Rest of Asia Pacific RNA Analysis Market by Technology
8.3.5.7.3 Rest of Asia Pacific RNA Analysis Market by End-use
8.3.5.7.4 Rest of Asia Pacific RNA Analysis Market by Application
8.4 LAMEA RNA Analysis Market
8.4.1 LAMEA RNA Analysis Market by Product
8.4.1.1 LAMEA Kits & Reagents Market by Country
8.4.1.2 LAMEA Instruments Market by Country
8.4.1.3 LAMEA Services Market by Country
8.4.2 LAMEA RNA Analysis Market by Technology
8.4.2.1 LAMEA Real Time-PCR (qPCR) Technology Market by Country
8.4.2.2 LAMEA Sequencing Technology Market by Country
8.4.2.3 LAMEA Microarray Technology Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA RNA Analysis Market by End-use
8.4.3.1 LAMEA Government Institutes & Academic Centers Market by Country
8.4.3.2 LAMEA Hospitals & Clinics Market by Country
8.4.3.3 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
8.4.3.4 LAMEA Contract Research Organizations (CROs) Market by Country
8.4.4 LAMEA RNA Analysis Market by Application
8.4.4.1 LAMEA Infectious Diseases & Pathogenesis Market by Country
8.4.4.2 LAMEA Epigenetics Market by Country
8.4.4.3 LAMEA RNA Structure & Molecular Dynamics Market by Country
8.4.4.4 LAMEA Development & Delivery of RNA Therapeutics Market by Country
8.4.4.5 LAMEA Construction of RNA Expression Atlas Market by Country
8.4.4.6 LAMEA Alternative RNA Splicing Market by Country
8.4.4.7 LAMEA Others Market by Country
8.4.5 LAMEA RNA Analysis Market by Country
8.4.5.1 Brazil RNA Analysis Market
8.4.5.1.1 Brazil RNA Analysis Market by Product
8.4.5.1.2 Brazil RNA Analysis Market by Technology
8.4.5.1.3 Brazil RNA Analysis Market by End-use
8.4.5.1.4 Brazil RNA Analysis Market by Application
8.4.5.2 Argentina RNA Analysis Market
8.4.5.2.1 Argentina RNA Analysis Market by Product
8.4.5.2.2 Argentina RNA Analysis Market by Technology
8.4.5.2.3 Argentina RNA Analysis Market by End-use
8.4.5.2.4 Argentina RNA Analysis Market by Application
8.4.5.3 UAE RNA Analysis Market
8.4.5.3.1 UAE RNA Analysis Market by Product
8.4.5.3.2 UAE RNA Analysis Market by Technology
8.4.5.3.3 UAE RNA Analysis Market by End-use
8.4.5.3.4 UAE RNA Analysis Market by Application
8.4.5.4 Saudi Arabia RNA Analysis Market
8.4.5.4.1 Saudi Arabia RNA Analysis Market by Product
8.4.5.4.2 Saudi Arabia RNA Analysis Market by Technology
8.4.5.4.3 Saudi Arabia RNA Analysis Market by End-use
8.4.5.4.4 Saudi Arabia RNA Analysis Market by Application
8.4.5.5 South Africa RNA Analysis Market
8.4.5.5.1 South Africa RNA Analysis Market by Product
8.4.5.5.2 South Africa RNA Analysis Market by Technology
8.4.5.5.3 South Africa RNA Analysis Market by End-use
8.4.5.5.4 South Africa RNA Analysis Market by Application
8.4.5.6 Nigeria RNA Analysis Market
8.4.5.6.1 Nigeria RNA Analysis Market by Product
8.4.5.6.2 Nigeria RNA Analysis Market by Technology
8.4.5.6.3 Nigeria RNA Analysis Market by End-use
8.4.5.6.4 Nigeria RNA Analysis Market by Application
8.4.5.7 Rest of LAMEA RNA Analysis Market
8.4.5.7.1 Rest of LAMEA RNA Analysis Market by Product
8.4.5.7.2 Rest of LAMEA RNA Analysis Market by Technology
8.4.5.7.3 Rest of LAMEA RNA Analysis Market by End-use
8.4.5.7.4 Rest of LAMEA RNA Analysis Market by Application

Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
9.10.2.2 Geographical Expansions:

TABLE 1 Global RNA Analysis Market, 2018 - 2021, USD Million
TABLE 2 Global RNA Analysis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– RNA Analysis Market
TABLE 4 Product Launches And Product Expansions– RNA Analysis Market
TABLE 5 Acquisition and Mergers– RNA Analysis Market
TABLE 6 Geographical Expansions – RNA Analysis Market
TABLE 7 Global RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 8 Global RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 9 Global Kits & Reagents Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Kits & Reagents Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Instruments Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Instruments Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Services Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Services Market by Region, 2022 - 2028, USD Million
TABLE 15 Global RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 16 Global RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 17 Global Real Time-PCR (qPCR) Technology Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Real Time-PCR (qPCR) Technology Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Sequencing Technology Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Sequencing Technology Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Microarray Technology Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Microarray Technology Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 25 Global RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 26 Global RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 27 Global Government Institutes & Academic Centers Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Government Institutes & Academic Centers Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Hospitals & Clinics Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Hospitals & Clinics Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Pharmaceutical & Biotechnology Companies Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Pharmaceutical & Biotechnology Companies Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Contract Research Organizations (CROs) Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Contract Research Organizations (CROs) Market by Region, 2022 - 2028, USD Million
TABLE 35 Global RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 36 Global RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 37 Global Infectious Diseases & Pathogenesis Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Infectious Diseases & Pathogenesis Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Epigenetics Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Epigenetics Market by Region, 2022 - 2028, USD Million
TABLE 41 Global RNA Structure & Molecular Dynamics Market by Region, 2018 - 2021, USD Million
TABLE 42 Global RNA Structure & Molecular Dynamics Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Development & Delivery of RNA Therapeutics Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Development & Delivery of RNA Therapeutics Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Construction of RNA Expression Atlas Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Construction of RNA Expression Atlas Market by Region, 2022 - 2028, USD Million
TABLE 47 Global Alternative RNA Splicing Market by Region, 2018 - 2021, USD Million
TABLE 48 Global Alternative RNA Splicing Market by Region, 2022 - 2028, USD Million
TABLE 49 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 50 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 51 Global RNA Analysis Market by Region, 2018 - 2021, USD Million
TABLE 52 Global RNA Analysis Market by Region, 2022 - 2028, USD Million
TABLE 53 North America RNA Analysis Market, 2018 - 2021, USD Million
TABLE 54 North America RNA Analysis Market, 2022 - 2028, USD Million
TABLE 55 North America RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 56 North America RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 57 North America Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 63 North America RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 64 North America RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 65 North America Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 73 North America RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 74 North America RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 75 North America Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 78 North America Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 79 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 83 North America RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 84 North America RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 85 North America Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 86 North America Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 88 North America Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 89 North America RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 90 North America RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 91 North America Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 93 North America Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 94 North America Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 95 North America Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 96 North America Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 97 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 98 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 99 North America RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 100 North America RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 101 US RNA Analysis Market, 2018 - 2021, USD Million
TABLE 102 US RNA Analysis Market, 2022 - 2028, USD Million
TABLE 103 US RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 104 US RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 105 US RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 106 US RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 107 US RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 108 US RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 109 US RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 110 US RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 111 Canada RNA Analysis Market, 2018 - 2021, USD Million
TABLE 112 Canada RNA Analysis Market, 2022 - 2028, USD Million
TABLE 113 Canada RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 114 Canada RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 115 Canada RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 116 Canada RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 117 Canada RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 118 Canada RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 119 Canada RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 120 Canada RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 121 Mexico RNA Analysis Market, 2018 - 2021, USD Million
TABLE 122 Mexico RNA Analysis Market, 2022 - 2028, USD Million
TABLE 123 Mexico RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 124 Mexico RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 125 Mexico RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 126 Mexico RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 127 Mexico RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 128 Mexico RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 129 Mexico RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 130 Mexico RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 131 Rest of North America RNA Analysis Market, 2018 - 2021, USD Million
TABLE 132 Rest of North America RNA Analysis Market, 2022 - 2028, USD Million
TABLE 133 Rest of North America RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 134 Rest of North America RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 135 Rest of North America RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 136 Rest of North America RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 137 Rest of North America RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 138 Rest of North America RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 139 Rest of North America RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 140 Rest of North America RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 141 Europe RNA Analysis Market, 2018 - 2021, USD Million
TABLE 142 Europe RNA Analysis Market, 2022 - 2028, USD Million
TABLE 143 Europe RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 144 Europe RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 145 Europe Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 149 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 152 Europe RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 153 Europe Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 154 Europe Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 155 Europe Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 156 Europe Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 157 Europe Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 162 Europe RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 163 Europe Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 168 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 169 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 172 Europe RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 173 Europe Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 174 Europe Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 175 Europe Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 176 Europe Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 177 Europe RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 178 Europe RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 179 Europe Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 180 Europe Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 181 Europe Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 182 Europe Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 183 Europe Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 184 Europe Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 185 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 186 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 187 Europe RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 188 Europe RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 189 Germany RNA Analysis Market, 2018 - 2021, USD Million
TABLE 190 Germany RNA Analysis Market, 2022 - 2028, USD Million
TABLE 191 Germany RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 192 Germany RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 193 Germany RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 194 Germany RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 195 Germany RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 196 Germany RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 197 Germany RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 198 Germany RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 199 UK RNA Analysis Market, 2018 - 2021, USD Million
TABLE 200 UK RNA Analysis Market, 2022 - 2028, USD Million
TABLE 201 UK RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 202 UK RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 203 UK RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 204 UK RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 205 UK RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 206 UK RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 207 UK RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 208 UK RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 209 France RNA Analysis Market, 2018 - 2021, USD Million
TABLE 210 France RNA Analysis Market, 2022 - 2028, USD Million
TABLE 211 France RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 212 France RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 213 France RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 214 France RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 215 France RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 216 France RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 217 France RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 218 France RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 219 Russia RNA Analysis Market, 2018 - 2021, USD Million
TABLE 220 Russia RNA Analysis Market, 2022 - 2028, USD Million
TABLE 221 Russia RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 222 Russia RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 223 Russia RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 224 Russia RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 225 Russia RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 226 Russia RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 227 Russia RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 228 Russia RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 229 Spain RNA Analysis Market, 2018 - 2021, USD Million
TABLE 230 Spain RNA Analysis Market, 2022 - 2028, USD Million
TABLE 231 Spain RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 232 Spain RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 233 Spain RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 234 Spain RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 235 Spain RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 236 Spain RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 237 Spain RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 238 Spain RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 239 Italy RNA Analysis Market, 2018 - 2021, USD Million
TABLE 240 Italy RNA Analysis Market, 2022 - 2028, USD Million
TABLE 241 Italy RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 242 Italy RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 243 Italy RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 244 Italy RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 245 Italy RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 246 Italy RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 247 Italy RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 248 Italy RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 249 Rest of Europe RNA Analysis Market, 2018 - 2021, USD Million
TABLE 250 Rest of Europe RNA Analysis Market, 2022 - 2028, USD Million
TABLE 251 Rest of Europe RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 252 Rest of Europe RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 253 Rest of Europe RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 254 Rest of Europe RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 255 Rest of Europe RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 256 Rest of Europe RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 257 Rest of Europe RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 258 Rest of Europe RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 259 Asia Pacific RNA Analysis Market, 2018 - 2021, USD Million
TABLE 260 Asia Pacific RNA Analysis Market, 2022 - 2028, USD Million
TABLE 261 Asia Pacific RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 262 Asia Pacific RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 263 Asia Pacific Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 264 Asia Pacific Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 265 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
TABLE 266 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
TABLE 267 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
TABLE 268 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
TABLE 269 Asia Pacific RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 270 Asia Pacific RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 271 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 272 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 273 Asia Pacific Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 274 Asia Pacific Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 275 Asia Pacific Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 276 Asia Pacific Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 277 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 278 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 279 Asia Pacific RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 280 Asia Pacific RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 281 Asia Pacific Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 282 Asia Pacific Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 283 Asia Pacific Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 284 Asia Pacific Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 285 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 286 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 287 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 288 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 289 Asia Pacific RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 290 Asia Pacific RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 291 Asia Pacific Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 292 Asia Pacific Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 293 Asia Pacific Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 294 Asia Pacific Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 295 Asia Pacific RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 296 Asia Pacific RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 297 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 298 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 299 Asia Pacific Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 300 Asia Pacific Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 301 Asia Pacific Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 302 Asia Pacific Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 303 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 304 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 305 Asia Pacific RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 306 Asia Pacific RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 307 China RNA Analysis Market, 2018 - 2021, USD Million
TABLE 308 China RNA Analysis Market, 2022 - 2028, USD Million
TABLE 309 China RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 310 China RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 311 China RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 312 China RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 313 China RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 314 China RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 315 China RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 316 China RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 317 Japan RNA Analysis Market, 2018 - 2021, USD Million
TABLE 318 Japan RNA Analysis Market, 2022 - 2028, USD Million
TABLE 319 Japan RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 320 Japan RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 321 Japan RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 322 Japan RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 323 Japan RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 324 Japan RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 325 Japan RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 326 Japan RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 327 India RNA Analysis Market, 2018 - 2021, USD Million
TABLE 328 India RNA Analysis Market, 2022 - 2028, USD Million
TABLE 329 India RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 330 India RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 331 India RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 332 India RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 333 India RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 334 India RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 335 India RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 336 India RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 337 South Korea RNA Analysis Market, 2018 - 2021, USD Million
TABLE 338 South Korea RNA Analysis Market, 2022 - 2028, USD Million
TABLE 339 South Korea RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 340 South Korea RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 341 South Korea RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 342 South Korea RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 343 South Korea RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 344 South Korea RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 345 South Korea RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 346 South Korea RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 347 Singapore RNA Analysis Market, 2018 - 2021, USD Million
TABLE 348 Singapore RNA Analysis Market, 2022 - 2028, USD Million
TABLE 349 Singapore RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 350 Singapore RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 351 Singapore RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 352 Singapore RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 353 Singapore RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 354 Singapore RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 355 Singapore RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 356 Singapore RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 357 Malaysia RNA Analysis Market, 2018 - 2021, USD Million
TABLE 358 Malaysia RNA Analysis Market, 2022 - 2028, USD Million
TABLE 359 Malaysia RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 360 Malaysia RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 361 Malaysia RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 362 Malaysia RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 363 Malaysia RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 364 Malaysia RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 365 Malaysia RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 366 Malaysia RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 367 Rest of Asia Pacific RNA Analysis Market, 2018 - 2021, USD Million
TABLE 368 Rest of Asia Pacific RNA Analysis Market, 2022 - 2028, USD Million
TABLE 369 Rest of Asia Pacific RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 370 Rest of Asia Pacific RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 371 Rest of Asia Pacific RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 372 Rest of Asia Pacific RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 373 Rest of Asia Pacific RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 374 Rest of Asia Pacific RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 375 Rest of Asia Pacific RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 376 Rest of Asia Pacific RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 377 LAMEA RNA Analysis Market, 2018 - 2021, USD Million
TABLE 378 LAMEA RNA Analysis Market, 2022 - 2028, USD Million
TABLE 379 LAMEA RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 380 LAMEA RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 381 LAMEA Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 382 LAMEA Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 383 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 384 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 385 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 386 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 387 LAMEA RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 388 LAMEA RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 389 LAMEA Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 390 LAMEA Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 391 LAMEA Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 392 LAMEA Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 393 LAMEA Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 394 LAMEA Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 395 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 396 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 397 LAMEA RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 398 LAMEA RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 399 LAMEA Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 400 LAMEA Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 401 LAMEA Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 402 LAMEA Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 403 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 404 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 405 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 406 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 407 LAMEA RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 408 LAMEA RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 409 LAMEA Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 410 LAMEA Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 411 LAMEA Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 412 LAMEA Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 413 LAMEA RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 414 LAMEA RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 415 LAMEA Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 416 LAMEA Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 417 LAMEA Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 418 LAMEA Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 419 LAMEA Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 420 LAMEA Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 421 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 422 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 423 LAMEA RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 424 LAMEA RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 425 Brazil RNA Analysis Market, 2018 - 2021, USD Million
TABLE 426 Brazil RNA Analysis Market, 2022 - 2028, USD Million
TABLE 427 Brazil RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 428 Brazil RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 429 Brazil RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 430 Brazil RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 431 Brazil RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 432 Brazil RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 433 Brazil RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 434 Brazil RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 435 Argentina RNA Analysis Market, 2018 - 2021, USD Million
TABLE 436 Argentina RNA Analysis Market, 2022 - 2028, USD Million
TABLE 437 Argentina RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 438 Argentina RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 439 Argentina RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 440 Argentina RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 441 Argentina RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 442 Argentina RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 443 Argentina RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 444 Argentina RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 445 UAE RNA Analysis Market, 2018 - 2021, USD Million
TABLE 446 UAE RNA Analysis Market, 2022 - 2028, USD Million
TABLE 447 UAE RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 448 UAE RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 449 UAE RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 450 UAE RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 451 UAE RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 452 UAE RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 453 UAE RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 454 UAE RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 455 Saudi Arabia RNA Analysis Market, 2018 - 2021, USD Million
TABLE 456 Saudi Arabia RNA Analysis Market, 2022 - 2028, USD Million
TABLE 457 Saudi Arabia RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 458 Saudi Arabia RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 459 Saudi Arabia RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 460 Saudi Arabia RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 461 Saudi Arabia RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 462 Saudi Arabia RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 463 Saudi Arabia RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 464 Saudi Arabia RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 465 South Africa RNA Analysis Market, 2018 - 2021, USD Million
TABLE 466 South Africa RNA Analysis Market, 2022 - 2028, USD Million
TABLE 467 South Africa RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 468 South Africa RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 469 South Africa RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 470 South Africa RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 471 South Africa RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 472 South Africa RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 473 South Africa RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 474 South Africa RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 475 Nigeria RNA Analysis Market, 2018 - 2021, USD Million
TABLE 476 Nigeria RNA Analysis Market, 2022 - 2028, USD Million
TABLE 477 Nigeria RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 478 Nigeria RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 479 Nigeria RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 480 Nigeria RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 481 Nigeria RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 482 Nigeria RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 483 Nigeria RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 484 Nigeria RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 485 Rest of LAMEA RNA Analysis Market, 2018 - 2021, USD Million
TABLE 486 Rest of LAMEA RNA Analysis Market, 2022 - 2028, USD Million
TABLE 487 Rest of LAMEA RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 488 Rest of LAMEA RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 489 Rest of LAMEA RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 490 Rest of LAMEA RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 491 Rest of LAMEA RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 492 Rest of LAMEA RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 493 Rest of LAMEA RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 494 Rest of LAMEA RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 495 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 496 Key Information – Danaher Corporation
TABLE 497 key Information – Agilent Technologies, Inc.
TABLE 498 Key Information – Thermo Fisher Scientific, Inc.
TABLE 499 Key Information – Qiagen N.V.
TABLE 500 key information – Illumina, Inc.
TABLE 501 Key Information – Bio-Rad Laboratories, Inc.
TABLE 502 Key Information – Eurofins Scientific Group
TABLE 503 key Information – Merck GrouP
TABLE 504 key Information – Promega Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
FIG 5 Global RNA Analysis Market Share by Product, 2021
FIG 6 Global RNA Analysis Market Share by Product, 2028
FIG 7 Global RNA Analysis Market by Product, 2018 - 2028, USD Million
FIG 8 Global RNA Analysis Market Share by Technology, 2021
FIG 9 Global RNA Analysis Market Share by Technology, 2028
FIG 10 Global RNA Analysis Market by Technology, 2018 - 2028, USD Million
FIG 11 Global RNA Analysis Market Share by End-use, 2021
FIG 12 Global RNA Analysis Market Share by End-use, 2028
FIG 13 Global RNA Analysis Market by End-use, 2018 - 2028, USD Million
FIG 14 Global RNA Analysis Market Share by Application, 2021
FIG 15 Global RNA Analysis Market Share by Application, 2028
FIG 16 Global RNA Analysis Market by Application, 2018 - 2028, USD Million
FIG 17 Global RNA Analysis Market Share by Region, 2021
FIG 18 Global RNA Analysis Market Share by Region, 2028
FIG 19 Global RNA Analysis Market by Region, 2018 - 2028, USD Million
FIG 20 Recent strategies and developments: F. Hoffmann-La Roche AG
FIG 21 Recent strategies and developments: Agilent Technologies, Inc.
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 Recent strategies and developments: Qiagen N.V.
FIG 24 Recent strategies and developments: Illumina, Inc.
FIG 25 Recent strategies and developments: Merck KGaA
FIG 26 Recent strategies and developments: Promega Corporation